98 related articles for article (PubMed ID: 12451320)
1. Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure.
Hikosaka M; Yuasa F; Yuyama R; Mimura J; Kawamura A; Motohiro M; Iwasaki M; Sugiura T; Iwasaka T
J Cardiovasc Pharmacol; 2002 Dec; 40(6):875-80. PubMed ID: 12451320
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin II (AT1) receptor blockade on cardiac vagal control in heart failure.
Vaile JC; Chowdhary S; Osman F; Ross HF; Fletcher J; Littler WA; Coote JH; Townend JN
Clin Sci (Lond); 2001 Dec; 101(6):559-66. PubMed ID: 11724639
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure.
Murakami H; Liu JL; Zucker IH
Hypertension; 1997 Feb; 29(2):564-9. PubMed ID: 9040439
[TBL] [Abstract][Full Text] [Related]
4. The effects of clonidine on arterial baroreflex sensitivity and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with left ventricular dysfunction.
Yuasa F; Kawamura A; Yokoe H; Yoshida S; Murakawa K; Sugiura T; Iwasaka T
Clin Physiol Funct Imaging; 2011 Mar; 31(2):94-100. PubMed ID: 20969725
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension.
Grassi G; Turri C; Dell'Oro R; Stella ML; Bolla GB; Mancia G
J Hypertens; 1998 Dec; 16(12 Pt 1):1789-96. PubMed ID: 9869013
[TBL] [Abstract][Full Text] [Related]
6. Sodium intake influences hemodynamic and neural responses to angiotensin receptor blockade in rostral ventrolateral medulla.
DiBona GF; Jones SY
Hypertension; 2001 Apr; 37(4):1114-23. PubMed ID: 11304512
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.
Kishi T; Hirooka Y; Konno S; Sunagawa K
J Hypertens; 2012 Aug; 30(8):1646-55. PubMed ID: 22728908
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Candesartan and Angiotensin-(1-7) Combination to Mito-TEMPO Treatment for Normalizing Blood Pressure and Sympathovagal Balance in (mREN2)27 Rats.
Nautiyal M; Shaltout HA; Chappell MC; Diz DI
J Cardiovasc Pharmacol; 2019 Mar; 73(3):143-148. PubMed ID: 30540685
[TBL] [Abstract][Full Text] [Related]
9. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure.
Dibner-Dunlap ME; Smith ML; Kinugawa T; Thames MD
J Am Coll Cardiol; 1996 Feb; 27(2):358-64. PubMed ID: 8557906
[TBL] [Abstract][Full Text] [Related]
10. Central angiotensin modulation of baroreflex control of renal sympathetic nerve activity in the rat: influence of dietary sodium.
DiBona GF
Acta Physiol Scand; 2003 Mar; 177(3):285-9. PubMed ID: 12608998
[TBL] [Abstract][Full Text] [Related]
11. Effects of amlodipine on sympathetic nerve traffic and baroreflex control of circulation in heart failure.
Grassi G; Spaziani D; Seravalle G; Bertinieri G; Dell'Oro R; Cuspidi C; Mancia G
Hypertension; 1999 Feb; 33(2):671-5. PubMed ID: 10024325
[TBL] [Abstract][Full Text] [Related]
12. Salt supresses baseline muscle sympathetic nerve activity in salt-sensitive and salt-resistant hypertensives.
Abrahão SB; Tinucci T; Santello JL; Mion D
J Hum Hypertens; 2002 Dec; 16(12):843-50. PubMed ID: 12522465
[TBL] [Abstract][Full Text] [Related]
13. Acute AT(1)-receptor blockade reverses the hemodynamic and baroreflex impairment in adult sheep exposed to antenatal betamethasone.
Shaltout HA; Rose JC; Figueroa JP; Chappell MC; Diz DI; Averill DB
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H541-7. PubMed ID: 20543085
[TBL] [Abstract][Full Text] [Related]
14. Candesartan cilexetil and renal hemodynamics in hypertensive patients.
Fridman K; Wysocki M; Friberg P; Andersson OK
Am J Hypertens; 2000 Sep; 13(9):1045-8. PubMed ID: 10981559
[TBL] [Abstract][Full Text] [Related]
15. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.
Mitrovic V; Willenbrock R; Miric M; Seferovic P; Spinar J; Dabrowski M; Kiowski W; Marks DS; Alegria E; Dukát A; Lenz K; Arens HA
Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683
[TBL] [Abstract][Full Text] [Related]
16. Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
Kasama S; Toyama T; Sumino H; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2007 Dec; 48(12):1993-2000. PubMed ID: 18006623
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of oral beta blockade on cardiovascular and sympathetic regulation.
Beloka SP; Gouveia S; Gujic M; Naeije R; Rocha AP; van de Borne P
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):323-31. PubMed ID: 19903982
[TBL] [Abstract][Full Text] [Related]
18. Baroreflex control of muscle sympathetic nerve activity in mild hypertension.
Meyrelles SS; Tinucci T; Hollanda HE; Mion D
Am J Hypertens; 1997 Feb; 10(2):162-7. PubMed ID: 9037323
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II exerts differential actions on renal nerve activity and heart rate.
Kumagai K; Reid IA
Hypertension; 1994 Oct; 24(4):451-6. PubMed ID: 8088910
[TBL] [Abstract][Full Text] [Related]
20. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
